(Q37598528)

21 August 2017

1 reference

title

New salicylate therapies for ulcerative colitis (English)

1 reference

21 August 2017

1 reference

Bruckstein AH

1

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 September 1990

1 reference

21 August 2017

published in

Postgraduate Medicine

1 reference

21 August 2017

volume

88

1 reference

21 August 2017

issue

3

1 reference

21 August 2017

page(s)

79-82, 84, 89

1 reference

Cortisone in ulcerative colitis; final report on a therapeutic trial.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704726

A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704726

An experiment to determine the active therapeutic moiety of sulphasalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704726

Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704726

Treatment of left-sided ulcerative colitis with 4-aminosalicylic acid enemas. A double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704726

The protective effects of sulphasalazine against ethanol-induced gastric damage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704726

4-Aminosalicylic acid, in contrast to 5-aminosalicylic acid, has no effect on arachidonic acid metabolism in human neutrophils, or on the free radical 1,1-diphenyl-2-picrylhydrazyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00325481.1990.11704726

10.1080/00325481.1990.11704726

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference